Smad2 and Smad3 cooperate and antagonize simultaneously in vertebrate neurogenesis by Míguez, David G. et al.
J
o
u
rn
a
l
o
f
C
e
ll
S
c
ie
n
c
e
Smad2 and Smad3 cooperate and antagonize
simultaneously in vertebrate neurogenesis
David G. Mı´guez1,2,*, Estel Gil-Guin˜o´n1, Sebastia´n Pons1,3 and Elisa Martı´1,*
1Instituto de Biologı´a Molecular de Barcelona, CSIC, C/Baldiri i Reixac 20, Barcelona 08028, Spain
2Departamento de Fı´sica de la Materia Condensada and Instituto Nicola´s Cabrera and IFIMAC, Universidad Auto´noma de Madrid, Campus de
Cantoblanco, 28046 Madrid, Spain
3Instituto de Investigaciones Biome´dicas de Barcelona, CSIC-IDIBAPS, C/Rosello´ 161, Barcelona 08036, Spain
*Authors for correspondence (david.gomez.miguez@uam.es; emgbmc@ibmb.csic.es)
Accepted 4 September 2013
Journal of Cell Science 126, 5335–5343
 2013. Published by The Company of Biologists Ltd
doi: 10.1242/jcs.130435
Summary
The transforming growth factor beta (TGF-b) pathway plays key roles in development and cancer. TGF-b signaling converges on the
Smad2 and Smad3 effectors, which can either cooperate or antagonize to regulate their transcriptional targets. Here we performed in
vivo and in silico experiments to study how such cooperativity and antagonism might function during neurogenesis. In vivo
electroporation experiments in the chick embryo neural tube show that Smad2 and Smad3 cooperate to promote neurogenesis, as well as
the transcription of Smad3-specific targets. Knockdown of Smad2 enhances neurogenesis and the transcription of Smad3-specific
targets. A mathematical model of the TGF-b pathway fits the experimental results and predicts that the proportions of the three different
trimeric complexes formed dictates the transcriptional responses of the R-Smad proteins. As such, Smad2 targets are activated solely by
the Smad2–Smad2–Smad4 complex, whereas Smad3 targets are activated both by Smad2–Smad3–Smad4 and Smad3–Smad3–Smad4
trimers. We have modeled the Smad responses onto arbitrary genes and propose that this mechanism might be extended to additional
activities of TGF-b in development and disease.
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Introduction
The transforming growth factor beta (TGF-b) pathway is one of
the most conserved and prolific signaling cascades (Massague´,
2000; ten Dijke and Hill, 2004). Despite its simple architecture,
this pathway is involved in the regulation of many processes,
including growth, proliferation, differentiation and survival.
Extracellular TGF-b and activin are ligands that bind to a type
II transmembrane receptor, triggering the assembly of the
tetrameric active ligand–receptor complex by binding to a type
I receptor. Active ligand–receptor complexes then recruit and
phosphorylate C-terminal residues of the downstream effectors
Smad2 and Smad3 (R-Smad proteins). Phosphorylated R-Smad
proteins form heterotrimeric complexes with Smad4 that enter
the nuclei and recruit co-factors in order to ultimately regulate
target gene expression (Fig. 1A–C) (Moustakas et al., 2001;
Moustakas and Heldin, 2002). These DNA-binding complexes
can contain two Smad2 and one Smad4 molecule (S224); two
Smad3 and one Smad4 (S334); or even one Smad2, one Smad3
and one Smad4 molecule (S234) (Shi and Massague´, 2003).
Despite their 91% amino acid sequence similarity, Smad2 and
Smad3 recruit different co-factors and target different regulatory
sequences (Brown et al., 2007). However, they often share
similar functions, playing redundant roles in ovarian granulosa
cells (Li et al., 2008), in zebrafish mesoderm induction (Jia et al.,
2008) and in other cellular contexts (Bernard, 2004). Moreover,
when introduced into the Smad2 locus, Smad3 can rescue the
Smad2-deletion phenotype in developing mouse embryos (Dunn
et al., 2005). However, Smad2 and Smad3 fulfil opposing roles in
breast cancer metastasis (Petersen et al., 2010) and regulation of
growth and cell migration in pancreatic adenocarcinoma cells
(Ungefroren et al., 2011), as well as in forkhead-dependent
transcription (Labbe´ et al., 1998). Moreover, transcriptional
profiling experiments showed that Smad3-activated genes are
repressed by Smad2 (Yang et al., 2003). How such similar
molecules can cooperate and/or antagonize distinct events
remains somewhat unclear.
In this study, we characterized the roles of Smad2 and Smad3
in the context of vertebrate neurogenesis, where activation of the
TGF-b pathway, in particular Smad3, has been shown to promote
cell-cycle exit and differentiation (Garcı´a-Campmany and Martı´,
2007). Our results show a complex interplay between Smad2 and
Smad3, where cooperation and antagonism occur simultaneously
in the same cellular context. Through in vivo experiments in
the chick embryo neural tube, we show that both knockdown and
overexpression of Smad2 enhances neurogenesis. We developed
a simplified mathematical model of the pathway in which all
the experimental observations fit with a scenario in which
neurogenesis is promoted by both S234 and S334 trimers.
Results and Discussion
Smad2 and Smad3 cooperate and act as antagonists
in neurogenesis
To study the roles of Smad2 and Smad3 in the developing neural
tube of the chick embryo in vivo, we first analyzed their
expression in neural tube sections. Strong immunostaining for
Smad2 and Smad3 was evident in the ventricular zone where
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neural progenitors reside, with some enrichment in the transition
zone (Fig. 1D,E). Although Smad2 is expressed throughout the
dorsal–ventral (DV) axis of the neural tube (Fig. 1D), Smad3
expression is restricted to particular DV domains (Fig. 1E), as
reported previously (Garcia-Campmany, 2007). Differentiated
neurons that were identified by the expression of RNA-binding
proteins HuC and HuD (HuC/D) did not express Smad2 (Fig. 1D)
or Smad3 (Fig. 1E), as confirmed by in situ hybridization, which
showed the marginal zone of the neural tube where differentiated
neurons reside to be devoid of Smad2 and Smad3 mRNA
transcripts (supplementary material Fig. S1). To quantify Smad2
and Smad3 protein expression within the ventricular zone,
Fig. 1. Smad2 and Smad3 expression
overlap in the developing neural tube.
(A–C) Scheme of the TGF-b pathway
(A) before, (B) during and (C) after ligand
activation. S2, Smad2; S3, Smad3; S4, Smad4.
(D,E) Selected sections co-immunostained for
Smad2 and Smad3, the pan-neural marker
HuC/D, and DAPI. (D) Smad2 expression
throughout the ventricular zone. (E) Smad3
expression in restricted DV domains of the
ventricular zone with no overlap with HuC/D
(boxed areas show the regions selected for
quantification). (F,G) Selected area for Smad2
and Smad3 quantification. Pixel intensity of
Smad2 (F) and Smad3 (G) immunostaining
versus distance to the lumen. Black lines
correspond to the average profile and crosses
correspond to single-cell values. Ratio of
nuclear to cytoplasmic staining intensity versus
distance to lumen for Smad2 (F) and Smad3
(G). Crosses correspond to single-cell
measurements and lines correspond to
polynomial fitting to illustrate the trend.
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fluorescence intensity was measured at the intermediate neural
tube (white rectangles in Fig. 1D,E) as a function of the distance
to the lumen. Both total and single-cell measurements of Smad2
and Smad3 inmunostaining intensity (black lines and crosses in
Fig. 1F,G, respectively) indicated an enrichment in the transition
zone. Moreover, single-cell measurements of the nuclear to
cytoplasmic fluorescence intensity ratio as a function of distance
to the lumen, showed that Smad2 and Smad3 are mainly located
in the cytoplasm. However, as the nuclei move towards the
transition zone, the average ratio of Smad2 and Smad3 within the
nuclei increases (black lines in Fig. 1F,G, respectively),
suggesting a potential transcriptional activation of Smad2 and
Smad3 in the transition zone, where neurogenesis occurs.
Neurogenesis in the neural tube involves the lateral migration
of neural progenitors committed to differentiation, as well as the
de novo expression of pan-neural markers such as HuC/D. Thus,
monitoring the position of electroporated cells by evaluating
EGFP expression together with that of HuC/D serves to assess
neurogenesis in vivo (Fig. 2A) (Garcı´a-Campmany and Martı´,
2007; Xie et al., 2011). When analyzed 48 hours post
electroporation (hpe) of either control (pCIG) or Smad2,
EGFP+ cells were evenly distributed throughout the ventricular
zone and the mantle zone (HuC/D+ cells: Fig. 2E,F), although
overexpression of Smad2 resulted in an increase in the total
protein detected in western blots (Fig. 2B) and through the
increased fluorescence intensity at the cellular level (Fig. 2C).
However, Smad3 promoted the lateral migration of EGFP+ cells;
a phenotype that was enhanced by the co-electroporation of
Smad2 and Smad3 (Fig. 2G,H). When quantified, a significantly
higher proportion of differentiated cells was detected after the
electroporation of Smad3 and Smad2/3 (% GFP+, HuC/D+ cells
at 48 hpe: 3361% controls, 3562% Smad2, 4963% Smad3,
6961% Smad2/3; Fig. 2I).
To test the requirement of Smad2/3 in neurogenesis, we
reduced their endogenous expression by electroporating short-
hairpin RNAs specific for chick Smad2 and Smad3.
Electroporation of shSmad2 strongly diminished Smad2 protein
expression (Fig. 2D,K), without affecting the endogenous
expression of Smad3 (supplementary material Fig. S2).
Conversely, electroporation of shSmad3 provoked a strong
reduction in Smad3 protein expression (Fig. 2D,M), without
affecting endogenous Smad2 expression (supplementary material
Fig. S2). However, whereas knockdown of Smad3 caused the
expected reduction in neurogenesis, knockdown of Smad2
resulted in a significant increase in neurogenesis (% GFP+,
HuC/D+ cells at 48 hpe: 4063% control, 6363% shSmad2,
2562% shSmad3; Fig. 2N). Together, these results suggest that
Smad2 cooperates with Smad3 in the activation of target genes
involved in neurogenesis, whereas it also antagonizes Smad3
activity in the same cellular context.
Smad2 and Smad3 cooperate and antagonize in Smad3-
specific transcription
In order to dissect out the transcriptional responses mediated by
Smad2 and Smad3, we expressed vectors containing luciferase
reporters driven by either Smad2-specific [the activin response
element (ARE)] (Chen et al., 1996) or Smad3-specific (-CAGA-)
(Dennler et al., 1998) response elements (Fig. 3A–D) in the chick
neural tube. The ARE reporter was activated 24 hpe of Smad2 in
the chick neural tube, but not after Smad3 electroporation.
However, co-electroporation of Smad3 with Smad2 interestingly
resulted in a strong decrease in ARE activity compared with that
obtained with the same concentration of Smad2 alone (,36
reduction), reflecting antagonism between Smad2 and Smad3 in
the regulation of the Smad2-specific targets (Fig. 3B). By
contrast, the CAGA reporter was strongly activated by Smad3
but not by Smad2 electroporation. However, co-electroporation
of Smad3 with Smad2 enhanced CAGA activity up to fivefold
that of Smad3 alone, reflecting the cooperation between the
Smad2 and Smad3 in the regulation of Smad3-specific targets
(Fig. 3C).
Because knockdown of Smad2 resulted in increased
neurogenesis, we assessed the transcriptional responses in the
absence of either Smad2 or Smad3. The weak endogenous
responses to the ARE reporter did not allow its activity to be
monitored following loss of function, whereas knockdown of
Smad3 (24 hpe of shSmad3) did reduce the activity of the CAGA
reporter (Fig. 3D). Interestingly, knockdown of Smad2 resulted in
strong activation (,206) of the CAGA reporter (Fig. 3D).
Because Smad3 expression levels were not increased after
shSmad2 electroporation (supplementary material Fig. S2), these
results suggest that the presence of Smad2 prevents Smad3 from
activating its own targets, provoking an antagonistic effect.
To confirm these results at the cellular level, we co-
electroporated Smad2 and Smad3 with the CAGA reporter
driving EGFP expression (Fig. 3E–K). Although Smad2 was
unable to activate CAGA-EGFP above control levels (Fig. 3E,F),
Smad3 induced strong cell-autonomous activation of the reporter
(Fig. 3G). Co-electroporation of Smad2 and Smad3 produced
strong EGFP expression similar to that of Smad3 alone, which was
probably due to saturation of EGFP expression (data not shown).
Moreover, knockdown of Smad2, but not Smad3, induced cell-
autonomous expression of CAGA-EGFP (Fig. 3H–K), which is
consistent with the results from the luciferase experiments.
Mathematical model of the TGF-b pathway with differential
activity predicts the dual cooperativity and antagonism of
R-Smad proteins
The experimental data reflect a complex interplay between
Smad2 and Smad3 in the regulation of their specific targets: a
relationship that is reproduced in neurogenesis. In gain-of-
function (GOF) experiments, Smad2 and Smad3 cooperate to
regulate Smad3 targets and neurogenesis while antagonizing the
regulation of Smad2-specific targets. Conversely, in loss-of-
function (LOF) conditions Smad2 and Smad3 antagonize the
regulation of Smad3-specific targets and neurogenesis. To
understand the mechanisms driving such cellular responses, we
developed a simplified theoretical model of the TGF-b pathway
(see the Materials and Methods). Models have been developed
previously to study nucleo-cytoplasmic shuttling (Clarke et al.,
2006; Schmierer et al., 2008; Clarke and Liu, 2008), signal
processing (Cellie`re et al., 2011), the generation of transient
responses (Melke et al., 2006; Vilar et al., 2006; Zi et al., 2011)
and the role of endocytosis (Zi and Klipp, 2007) in the TGF-b
signaling pathway. However, to our knowledge, no model has
been developed to predict how transcriptional responses are
regulated.
We developed such a model that simulates the transcription of
two arbitrary genes specific for Smad2 (Fig. 4A, black lines) and
Smad3 (Fig. 4A, red lines). Increasing Smad2 levels (,76, based
on experimental data) enhances Smad2 target transcription (,76
increase) without significantly affecting direct Smad3 targets
Smad2 and Smad3 in neurogenesis 5337
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Fig. 2. Smad2 and Smad3 cooperate
and antagonize in neurogenesis.
(A) Schematic representation of DNA
injection, electroporation and section of
transfected chick embryo neural tube.
(B) Total protein levels (Smad2 and
Smad3) measured by western blot in chick
embryo neural tube (C, control)
electroporated with Smad2 (S2), Smad3
(S3) or co-electroporated with both Smad2
and Smad3 (S2/S3). (C) Quantification of
immunofluorescence intensity in control
cells and in cells electroporated with
Smad2 and Smad3. (D) Quantification of
immunofluorescence intensity in control
cells, and cells electroporated with
shSmad2 and shSmad3.
(E–H) Representative confocal sections
after electroporation of indicated DNAs
(EGFP+ cells), immunostained for the pan-
neural marker HuC/D (purple) and for
DAPI (blue). (I) Quantification of
electroporated (EGFP+) cells that are
differentiated (HuC/D+), in each condition.
(J–M) Representative confocal sections
after electroporation of indicated DNAs
(EGFP+ cells, green), immunostained for
the pan-neural marker HuC/D (purple) and
for Smad2 (K) or Smad3 (M) (red; boxed
areas show the region selected for
quantification). (N) Quantification of
electroporated (EGFP+) cells that are
differentiated (HuC/D+), in each condition.
Error bars represent s.e.m.
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(Fig. 4A). However, increasing Smad3 (,126, based on
experimental data) enhances transcription of Smad3 (,36
increase) targets while reducing transcription of specific Smad2
targets (,76 decrease; Fig. 4A). A simultaneous increase in
Smad2 and Smad3 reduces Smad2-specific targets compared with
the transcription provoked by Smad2 alone (,1.26 decrease),
whereas it enhances Smad3-specific transcription (,1.56increase)
compared with Smad3 alone. Moreover, the model predicts that a
reduction in Smad2 levels (,96 decrease) increases Smad3-
specific targets (,36 increase; Fig. 4A, LOF). Together, these in
silico experiments qualitatively reproduce in vivo responses for
Smad2- and Smad3-specific target genes (Fig. 4B–D).
Overall, the mathematical model reproduced the experimental
data when we consider that Smad4 is not limiting for the
formation of the heterotrimers, and that the transcriptional trimers
are formed reflecting the concentration of Smad2 and Smad3. In
the wild-type state, R-Smad proteins interact with one another
and with Smad4 to form each type of possible heterotrimer (S224,
S234 and S334). However, Smad2 targets are activated solely by
the S224 complex, whereas Smad3 targets are activated both by
S234 and S334. Augmenting the amount of Smad2 favors the
formation of S224, and reduces the formation of S234 and S334
trimers. Conversely, increasing Smad3 favors the formation of
the S334, and reduces that of S234 and S224 complexes. Similarly,
Fig. 3. Smad2 and Smad3 cooperate and antagonize in specific targets of transcription. (A) Schematic representation of DNA injection, electroporation and
luciferase assay in transfected chick embryo neural tube. (B) Luciferase activity driven by the Smad2-specific ARE reporter after electroporation of indicated
DNAs (concentration of electroporated DNA maintained constant for all experiments). (C,D) Activity of the Smad3-specific CAGA reporter after electroporation
of indicated DNAs. Error bars represent s.e.m. (E–G) Representative confocal sections after co-electroporation of the CAGA-EGFP with the indicated DNAs.
H2b-RFP (red) is used as electroporation control, FLAG (blue) staining identify the electroporated DNAs, EGFP (green) identify the activated reporter.
(H–K) Representative confocal sections after co-electroporation of the CAGA-EGFP with the indicated DNAs. H2b-RFP (red) is used as electroporation control,
anti-Smad2 (blue) staining identify endogenous Smad2 expression, EGFP (green) identify the activated reporter.
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a reduction in Smad2 would therefore reduce the formation of
S224, and increase the formation of S234 and S334, thereby
resulting in the activation of Smad3-specific targets and
enhanced neurogenesis (Fig. 4B–D).
To experimentally test the outcome of this in silico model, we
quantified the trimer formation in each experimental condition
(Fig. 4E,F). In the wild-type state, the chick embryo neural tube
contains the S234 trimer (Fig. 4F), whereas when Smad2 is
overexpressed, the S224 trimer preferentially forms, without
affecting the Smad3-specific transcription of neurogenic targets
(Fig. 4F,G). Smad3 overexpression results in the preferential
formation of the S334 trimer, which enhances Smad3-specific
transcription and neurogenesis (Fig. 4F,G). Similarly, co-expression
of Smad2 and Smad3 enhances transcription and neurogenesis of
Smad3 by promoting the formation of the S234 trimer (Fig. 4F,G).
Here we show in vivo and in silico that the formation of
transcriptionally active Smad2/3 hetero-trimers dictates the
dynamics of Smad2- and Smad3-specific transcription.
Although clearly modulated by Smad2, the role of TGF-b in
neurogenesis follows the trend of Smad3 direct targets: it is
enhanced after Smad3 GOF alone or in combination with Smad2,
diminished after Smad3 LOF and increased after Smad2 LOF.
Fig. 4. Numerical model of the pathway
predicts the dual antagonism and
cooperativity between the R-Smad proteins.
(A) Temporal evolution of transcription of
Smad2 (S2)-specific targets (black dotted line)
and Smad3 (S3)-specific targets (red dotted
line) after gain-of-function (GOF) and loss-of-
function (LOF). Wild-type time evolution
corresponds to the solid black line (S2-specific
targets) and solid red line (S3-specific targets).
(B–D) Bar diagrams of maximum activation
levels obtained by the in silico model, to be
compared with the experimental data shown in
Fig. 3B–D. (E) Schematic representation of
DNA injection, electroporation and protein
extraction for co-immunoprecipitation. (F) Co-
immunoprecipitation of Smad2, Smad3 and
Smad4. In the wild-type condition, the chick
embryo neural tube contains the S234 trimer.
Smad2 electroporation increases the S224
trimer, Smad3 electroporation increases S334
trimer, co-electroporation of Smad2 and Smad3
results in the formation of the S234 trimer.
Smad4 (HA) is constant. (G) Schematic model
of the formation of transcriptional complexes
and regulation of target genes after wild-type
conditions, GOF of Smad2, GOF of Smad3 and
LOF of Smad2. Size of arrows in promoter
illustrate increase or decrease of transcription
compared with the wild type.
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This correlates with the binding of Smad3, but not Smad2, to the
stress response factor ATF3 in response to TGF-b, which
mediates the repression of transcription of Id1 (inhibitor of
DNA binding 1) (Kang et al., 2003). Additional direct targets
controlling proliferation and differentiation might include
p21CIP1 and p15INK4b, because their regulatory regions have
binding sites for Smad3 (Gomis et al., 2006).
Our model predicts an increase in Smad2-driven transcription
after Smad3 LOF, which we could not detect in our in vivo
experiments owing to the poor sensitivity of the ARE-luciferase
reporter. This prediction is consistent with the results in tissue culture
experiments where the activity of the ARE reporter is reduced in
Smad2-null cells, whereas it is activated in Smad3-null cells (Piek
et al., 2001). It also fits the data showing that TLP, a TRAP-1-like
protein that does not phosphorylate R-Smad proteins, represses the
ability of Smad3 to form a transcriptionally active complex while
increasing Smad2-driven transcription (Felici et al., 2003).
We propose that the mechanism reported in this study is
responsible for the divergence between studies that focused on
comparing the functions of Smad2 and Smad3 in other biological
contexts. Indeed, this dual co-operation/antagonism not only
influences neurogenesis but also affects other biological events
regulated by the TGF-b pathway. A deeper understanding of how
R-Smad proteins interact will be crucial to understand the
dynamics and function of the TGF-b pathway in order to develop
more efficient treatments for diseases in which this pathway is
compromised, because impairment of the growth inhibitory
function of TGF-b is considered to be a hallmark of cancer
(Dennler et al., 1999; Hanahan and Weinberg, 2000).
Materials and Methods
Mathematical model
The models consist of a set of ordinary differential equations solved numerically
using a Matlab script developed in-house (The Mathworks, Natick, MA), and
based on the following interactions (code available upon request):
TGF bRzS2K{{{{{{{{{{{{{{{{{{{{I
kz
1
,MMTBR1
k{
1
TGF bRzSp2 ð1Þ
TGF bRzS3K{{{{{{{{{{{{{{{{{{{{I
kz
2
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2
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p
3 ð2Þ
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3
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5
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5
S23 ð5Þ
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6
k{
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TGbR, S2 and S3 correspond to concentrations of the active receptor complex and
unphosphorylated Smad2 and Smad3 respectively. Equations 3–5 account for
binding of the phosphorylated R-Smad proteins S
p
2 and S
p
3 to form homodimers S22,
S33, and heterodimers S23. These complexes bind via Eq. 6 to Smad4 (S4), forming
the three possible heterotrimers S224, S334, S234 that can potentially enter the nuclei
and bind to specific regulatory sequences to regulate transcription regulated by
Smad2 and Smad3-specific binding sites.
S224 ?
kz
7
,MMS
targets of S2 ð7Þ
S234 ?
kz
7
,MMS
targets of S3 ð8Þ
S334 ?
kz
8
,MMS
targets of S3 ð9Þ
Eqs. 7 and 9 account for the transcription of the targets of S2 and S3 activated
by the S224 and S334 complex, respectively. There is no experimental evidence of
how the heterotrimer S234 regulates S2- or S3-specific transcription, but our
experimental data (Fig. 3C) show strong activation of the S3-specific CAGA
sequence when Smad2 and Smad3 are co-electroporated, suggesting a role of S234
in S3-specific transcription. This is introduced in the model via Eq. 8.
We consider a Michaelis–Menten type of interaction for the phosphorylation of the
R-Smad proteins (Eqs. 1,2). Michaelis–Menten constants and phosphorylation rates
of each of the R-Smad proteins by the TGFbR receptor were chosen to be equal.
Transcription was computed as a Hill function of the amount of active complex with
no cooperativity. Parameter values (supplementary material Table S1) and parameter
selection are discussed in detail in the selection of model parameters section.
Several authors (e.g. Labbe´ et al., 1998) hypothesize that the antagonism emerges
from competition of the R-Smad proteins to bind to Smad4, but the fact that the
pathway can get activated up to 20 times above the endogenous levels (Fig. 3C,D)
reflects that the amount of Smad4 is not the limiting reactant in the reaction in the wild-
type situation. In addition, this hypothesis does not explain the strong cooperativity in
Smad3 direct targets when combining Smad2 with Smad3, explained by our model.
The differential equations derived from this model are as follows:
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Selection of model parameters
Concentration and activity of ½S2t~0, ½S3t~0 and ½S4t~0
Experimental measurements of total concentration of Smad2, Smad3 and Smad4
have been performed in a specific cell type (Clarke et al., 2006), reporting values
of 100,000, 20,000 and 100,000 total molecules per cell of Smad2, Smad3 and
Smad4, respectively. Assuming a cell volume of 1610212 l, this gives us a value of
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½S2t~0WT 5166 nM, ½S3t~0WT 533 nM, ½S4t~0WT 5166 nM. Because wild-type values of
Smad2, Smad3 and Smad4 are likely to be very cell-type dependent, and our three
semi-quantitative estimations (immunofluorescence, western blot and co-
immunoprecipitation) reflect similar values for Smad2 and Smad3, we decided
to use for the model a standard value of 100 nM for all three Smad proteins, which
is close to the experimental measurements reported previously (Clarke et al.,
2006). Our model predictions are robust against slight changes in Smad
concentration (within the same order of magnitude), and it also works when
using the exact values measured previously (Clarke et al., 2006).
To estimate the concentration after GOF, we performed experiments where we
electroporated Smad2 and Smad3 and immunostained neural tube sections 24 hpe
(supplementary material Fig. S3) This way, we can measure the change in
immunofluorescence intensity between not electroporated and electroporated cells.
The average increase in pixel intensity for Smad2 was 7.66, and for Smad3 was
12.16. This gives us a final values for ½S2t~0GOF51216 nM, ½S3t~0GOF5403 nM.
Quantification of this experiment is shown in Fig. 2H.
To estimate the concentration after LOF, we performed measurements of the
immunofluorescence intensity in cells electroporated with shRNA against Smad2
and Smad3 compared with control (supplementary material Fig. S3). The average
reduction in pixel intensity for Smad2 was 9.66, and for Smad3 was 10.16. This
gives us a final values of ½S2t~0LOF517.4 nM, ½S3t~0LOF53.3 nM. Quantification of
this experiment is shown in Fig. 2I.
The balance between phosphorylation and de-phosphorylation of the R-Smad
proteins has been shown to be a key mechanism to regulate the dynamics of
nuclear–cytoplasmic shuttling (Hill, 2009), so nuclear localization of the R-Smad
proteins can be used as a readout of the pathway activity. This way, the balance
between phosphorylation and de-phosphorylation in our model in conditions of
pathway activation, should mimic the experimental (i.e. most R-Smad
phosphorylated after pathway activation, and most R-Smad un-phosphorylated
when the pathway is inactive). Owing to the lack of experimental data regarding
the un-phosphorylation rate of R-Smad, for our model we use a standard value
used in generalized models involving phosphatase activity (Kholodenko et al.,
2000; Lipkow and Odde, 2008) and other models of k{1 ,k
{
2 51 s
{1.
Concentration and activity of TGFbR
Previous experimental data (Wakefield et al., 1987) and other previous TGFbR
models (Zi et al., 2011) use a value of total TGFbR2R2I51000. Our model does
not take into account receptor complex assembly and multimerization of receptor
subtypes (Clarke and Liu, 2008), so we assume 20% of these values of total
[TGFbR2TypeI2R] as active after ligand stimulation. Because these are
membrane proteins, to calculate the concentration, we assume that they are
distributed in a volume equal to the cell area (given a cell radius value of 13 mm for
a spherical cell volume of 1610212 l) times the typical height of a ligand–receptor
complex (Allard et al., 2012) to obtain a value for [TGFb]5149 nM.
For the value of kz1 ,k
z
2 , we used the median value used previously (Clarke et al.,
2006). The value for the Michaelis–Menten constant has been selected within the
range listed (Clarke et al., 2006) (the median 2.896105 molecules resulted in very
low vales of R-Smad phosphorylation, so for lack of experimental data we assume
the minimum value listed (Clarke et al., 2006) of MMTGF bR5633
molecules51.03 nM. Values around ten times above or below the selected value
also produce simulation results in agreement with our experimental data.
Association and dissociation rates of R-Smad proteins
Due to lack of experimental values for association and dissociation of the R-Smad
proteins after phosphorylation, we have used values where after phosphorylation,
steady state is achieved in the order of seconds, and most of the R-Smad proteins are
in a dimer and trimer configuration when phosphorylated, as shown experimentally.
Experiments in Fig. 3C,D show that removing Smad2 increases activation of
Smad3-specific targets, suggesting that the presence of Smad2 prevents Smad3 from
activating its own targets. To take this into account, Smad3 affinity towards Smad3
was set lower than towards Smad2. This configuration induces more Smad2–Smad3
than Smad3–Smad3 complexes.
DNA regulation by the R-Smad heterotrimers
To our knowledge, experimental measurements of transcription rates of the
different heterotrimer complexes in specific targets for Smad2 and Smad3, have
not been reported. Previous systematic studies on mRNA production
(Schwanha¨usser et al., 2011) have shown an average of 10 mRNA molecules
per hour. In addition, the same studies have reported an average of 140 protein
molecules per mRNA. So values for kz7 50.38 s
{1 was chosen based on these data.
Fig. 3C shows that Smad2, when co-electroporated with Smad3, plays a role in
Smad3 transcription. Our model fits the experimental data when considering that
this role of the Smad2–Smad3–Smad4 complex in Smad3-specific targets is lower
that the role of the Smad3–Smad3–Smad4 complex, so we set kz8 519 s
{1
generically as 506 higher than kz7 . Differences between k
z
8 and k
z
7 above 256
also reproduce the experimental data. Values higher than 506 difference result in
higher differences between the different conditions, also in agreement with the
experimental data, where fold change in transcription compared with the wild type
is qualitatively higher than the model prediction.
Plasmids
Non-overlapping sequences of chicken Smad3 (bp 550–569) and Smad2 (bp 264–
283) were targeted following a previously published protocol. These fragments
were cloned into the pSHIN vector (Kojima et al., 2004) to generate short hairpin
RNAs (shRNAs) that could be electroporated into the neural tube. Controls were
performed by electroporating the empty pSHIN vector. Human N-terminal FLAG-
tagged Smad2, Smad3 and Smad4 were cloned into a pCIG vector.
In ovo electroporation
Chick embryos were staged according to Hamburger and Hamilton (Hamburger and
Hamilton, 1951). Plasmid DNA was injected into the lumen of HH stage 12 neural
tubes, electrodes were placed either side of the neural tube and electroporation was
performed using an Intracel Dual Pulse (TSS-100) electroporator delivering 50 ms
square pulses of 40 V. Transfected embryos were allowed to develop for 24–
48 hours, dissected and processed for immunohistochemistry, in situ hybridization,
luciferase assays or protein extraction.
Immunohistochemistry and in situ hybridization
For in situ hybridization, embryos were fixed overnight at 4 C˚ in 4%
paraformaldehyde diluted in PBS, rinsed and processed for whole-mount RNA in
situ hybridization using probes against chick Smad2 and Smad3 from the chicken EST
project following standard procedures. Immunofluorescence was performed on
transverse sections (40 mm) after fixation in 4% paraformaldehyde diluted in PBS for
2–4 hours at 4 C˚ using the following monoclonal antibodies: Smad2 (Cell Signaling,
5339), Smad3 (Abcam, ab28379), HuC/D (Molecular Probes, A-21271). Anti-HA and
anti-FLAG antibodies were generated in-house (Sebastian Pons Laboratory).
In vivo luciferase-reporter assay
Embryos were electroporated with the DNAs indicated with a firefly-luciferase
reporter construct driven by the ARE and CAGA promoter sequences, and a
Renilla luciferase reporter construct for normalization (Promega). Embryos were
harvested after 24 hours in ovo and only the interlimb sections of GFP-positive
neural tubes were dissected and homogenized on ice with a Dounce homogenizer
in passive lysis buffer. Firefly and Renilla luciferase activities were measured
using a dual luciferase reporter assay system (Promega).
Immunoprecipitation and western blotting
For the study of the S234 complexes by co-immunoprecipitation, embryos were
co-electroporated at HH14 with the DNAs indicated (the total amount of DNA
electroporated was normalized with the empty vector pCIG, n55 per condition)
and the neural tube was dissected at 24 hpe. The cells were lysed by sonication
pulses in lysis buffer (20 mM Tris-HCl, pH 7.4, 137 mM NaCl, 10% glycerol, 1%
NP-40, 1 mM CaCl2, 1 mM MgCl2, 0.05% sodium azide) supplemented with
protease inhibitors (1 mM PMSF, 1 mg/ml aprotinin and 1 mg/ml leupeptin,
Sigma). The insoluble material was removed by centrifugation and one tenth of the
resulting supernatant was reserved as the input material; the remaining volume was
immunoprecipitated for 4 hours at 4 C˚ with a monoclonal anti-HA agarose
conjugate (Sigma). The beads were washed three times and boiled with 26 SDS
loading buffer and the samples were resolved by 8% SDS-PAGE. After western
blotting, the membranes were incubated with the indicated primary antibodies and
infra-red-tagged secondary antibodies (anti-Rabbit IgG DyLight 800 conjugate and
anti-rabbit IgG DyLight 680 conjugate; Thermo). The membranes were scanned
using the Odyssey infrared imager (Li-Cor).
Quantification and data analysis
The ratio of differentiated electroporated cells was calculated by first quantifying the
number of EGFP+ cells and then by quantifying the HuC/D+ cells among those that
were electroporated. At least ten different confocal transversal sections of the neural
tube were quantified from at least three different electroporated embryos. The change
in immunofluorescence staining intensity was quantified in 50 electroporated cells
versus 50 non-electroporated cells in three different neural tube sections for each
condition (supplementary material Fig. S3). The bars represent the mean value and
the error bars represent the s.e.m. Statistical significance in terms of P-values was
calculated using the Z-test function in Numbers (Macintosh).
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